WHO Issues Dual Health Alerts: Obesity Drug Warning for Young Children, Low Plague Risk in Russia

The World Health Organization issued two significant global health advisories this week, cautioning against the use of obesity medications in children under 10 and assessing the epidemic risk following the plague-related death of a Russian laboratory technician as low.

In its latest guidelines released Oct. 7, the WHO warned that weight-loss drugs and obesity medications, including weight-loss injections, should not be administered to children younger than 10 years old, according to BBC News. The organization emphasized that care for young children struggling with obesity should center on lifestyle interventions, specifically healthy eating habits and regular physical exercise, rather than pharmaceutical treatments.

The guidelines signal a growing concern among global health authorities over the increasing use of weight-loss medications – including widely marketed injectable drugs – in younger populations. The WHO's position draws a clear boundary, urging medical practitioners and caregivers to prioritize non-medicinal approaches as the primary course of action for managing childhood obesity in early age groups, BBC News reported.

Separately, the WHO moved to reassure the international community over a potential plague scare in Russia. According to The Guardian, the organization confirmed that the risk of a broader epidemic remains low following the death of Darya Shipilova, a 28-year-old laboratory technician who worked at a plague research institute in Siberia. Shipilova died last week, two days after falling ill. Russian media reports suggested she may have become infected following an accident at her workplace, where dangerous pathogens are stored and studied, The Guardian reported. The WHO said it has detected no signs of a further outbreak since her death, and quarantine measures were implemented in the affected area.

The two developments underscore the WHO's continued role in monitoring and responding to both emerging infectious disease threats and longer-term public health challenges such as childhood obesity. While the plague case in Russia appears contained, health authorities are likely to scrutinize biosafety protocols at research facilities handling high-risk pathogens. Meanwhile, the new pediatric obesity guidelines reflect a broader global debate about the appropriate use of increasingly available weight-loss medications in vulnerable age groups.

The context provided does not include additional details on the specific obesity drugs referenced in the WHO guidelines or further information on the investigation into Shipilova's death. EME will continue to monitor both developments as more information becomes available.

*Sources: BBC News – Health (Oct. 7, 2026); The Guardian – Health (Oct. 6, 2026)*